The burgeoning role of global health diplomacy to alleviate suffering of cancer patients in low- and middle-income countries.
Adomako M., Kamiar A., Alshaikh A., Baines LS., Benson D., Bettcher DW., Cheema B., Corijn L., Fountain E., Gdaniec BG., Garonzik E., Harney M., Jindal RM., Jones K., Kerr D., Mehjabeen D., Vahid NP., Okonetuk E., Pompeu N., Skosana B., Tan S., Thokwane K., Welzel T.
The science of global health diplomacy (GHD) consists of cross-disciplinary, multistakeholder credentials comprised of national security, public health, international affairs, management, law, economics and trade policy. GHD is well placed to bring about better and improved multilateral stakeholder leverage and outcomes in the prevention and control of cancer. It is important to create an evidence base that provides clear and specific guidance for health practitioners in low- and middle-income countries (LMICs) through involvement of all stakeholders. GHD can assist LMICs to negotiate across multilateral stakeholders to integrate prevention, treatment and palliative care of cancer into their commercial and trade policies.